Features Screener Stocks Charts
Sign In Sign Up

Sequent Scientific Income Statement

NSE:SEQUENT | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year SEQUENT income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 13.81B 15.51B
Cost of Revenue -7.60B -8.12B
Gross Profit 6.21B 7.40B
Sales, General & Admin -5.49B -5.81B
Operating Income 108.31M 924.15M
Profit Before Tax -546.46M 443.06M
Net Income -296.13M 322.59M
Diluted Shares 249.88M 256.27M
Diluted EPS -1.44 0.85

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025